A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.
复制标题
和厚朴酚和雷帕霉素的新型联合治疗可有效限制 c-Met 诱导的肾癌细胞生长，并抑制参与免疫逃逸的肿瘤细胞 PD-L1 的表达。
DOI：
10.3390/cancers12071782
复制
发表时间：
2020
期刊：
影响因子：
5.2
通讯作者：
Pal,Soumitro
中科院分区：
文献类型：
--
作者：
Sabarwal,Akash;Chakraborty,Samik;Mahanta,Simran;Banerjee,Selina;Balan,Murugabaskar;Pal,Soumitro
